Feb 29th is #RareDiseaseDay and Kartos encourages you to learn more about the global movement that champions the cause of people living with rare diseases like #myelofibrosis.
Kartos Therapeutics, Inc.
Biotechnology Research
Redwood City, California 3,491 followers
Dedicated to the development of novel, targeted therapeutics that meaningfully improve the lives of patients with cancer
Über uns
Kartos Therapeutics is a privately held, clinical-stage biopharmaceutical company developing a potentially best-in-class MDM2 inhibitor. Launched in 2018 by proven industry veterans, we are a passionate team based in Redwood City, California, and Bellevue, Washington. We have brought together scientists and clinicians with a deep understanding of hematology and oncology and an experienced leadership team. Together, we’re building an exciting biotechnology company with a culture defined by caring, ambition, dedication, and teamwork!
- Website
-
http://www.kartosthera.com
External link for Kartos Therapeutics, Inc.
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Redwood City, California
- Typ
- In Privatbesitz
- Gegründet
- 2018
Standorte
-
Primäre
Wegbeschreibung erhalten
275 Shoreline Dr
Suite 100
Redwood City, California 94065, US